“showed a trend”

NP VDR mRNA Downregulation in LDD Patients Similar to blood VDR, the analysis of NP VDR expression also showed a trend toward lower levels in the LDD group compared to controls ( p = 0.018).

During negative emotion regulation, the decreased left SMA activation in the NSSI group showed a trend-level correlation with higher DERS scores ( r = −0.44, P = 0.018), which did not survive the Bonferroni-corrected threshold of P < 0.017.

The distribution profiles of neurite curvature of the control cases showed a trend depending on their age, resulting in an age-correlated decrease in the standard deviation of neurite curvature (Pearson’s r = -0.80, p = 0.018).

The PR group showed a trend of decreased frequency of CD4 + PD-1 + and CD8 + PD-1 + T cell subsets ( Figure 2(a) ) ( p =0.019, p =0.003).

Participants with MOH showed a trend toward higher PSQI global scores compared to those without MOH, which reached statistical significance only at Week 12 ( p = 0.019).

Patients after PFA showed a trend of higher uptake than controls, reaching the boundaries of statistical significance for SUV peak (2.43 ± 0.42 vs 1.28 ± 0.15 P = 0.02) and SUV mean (2.30 ± 0.46 vs 1.12 ± 0.08 P = 0.014).

The Welch’s t-tests, however, showed a trend with the board addition and a significant difference with board removal (C1 vs. + B: t = –2.4, df = 17.7, p = 0.02; C2 vs. –B: t = –5.7, df = 25.8, p = 0.00003).

This showed a trend toward poorer outcomes among patients with a tumor-only DDR alteration [PSA50: adjusted OR 0.29 (0.10-0.78), P = 0.02; PSA-PFS: adjusted HR 1.65 (0.95-2.87), P = 0.07; OS: adjusted HR 1.51 (0.73-3.10), P = 0.26].

Additionally, Delta stiffness showed a trend towards change (p = 0.02), while Delta CAP did not show such a trend (Supplementary Table 3 ).

As for orientation angular velocity, the linear mixed-model ANOVA showed a trend between the experienced and naive groups (F 1, 59 = 5.5, p < 0.02) ( Figure 3 B).

The pooled RCT data showed a trend for higher miscarriage rate in the control group, which was statistically significant (RR 0.73, 95% CI 0.56–0.96; p = 0.02).

In the overall model, Education remained significant (aPR: 1.20, p = 0.03), whereas Labour Intensive Services, which was significant in the primary analysis, lost its significance (aPR: 1.04, p = 0.63) and Knowledge Intensive Services which showed a trend in the primary analysis became significant (aPR: 1.21, p = 0.02).

In GAC, CLDN18.2 expression showed a trend towards less invasive growth ( p = 0.02) and less common lymph node metastasis ( p = 0.07) and was more often observed within the EBV-associated subtype ( p = 0.01).

Within the PD-1 hi populations, cells expressing either CXCR5 and/or CCR9 of pSS patients showed a trend of higher ICOS expression compared to HC but this was only significant in CCR9+ Tfh-like cells (28.6% and 55%, medians for HC and pSS, respectively, p = 0.02, Figure 2 B).

In the multivariable analysis, controlling for both female and male age, female age showed a trend toward significance (OR = 1.12, 95% CI: 1.02 - 1.23, p = 0.02), while male age showed no significant effect (OR = 0.99, 95% CI: 0.92 - 1.06, p = 0.75).

Especially towards the end of the experiment, biomass in the W treatment showed a trend of becoming higher than in the other two treatments, but a significant difference was only found between W and H treatments (KW test: chi 2 = 7.65, df = 2, p = .02, W‐H: p < .01) at the end of the second heatwave (day 21, Table S2 ).

Moreover, patients with appropriate ICD therapy showed a trend toward lower right ventricular ejection fraction (RVEF) (development, P = 0.02; validation cohort, P = 0.22), with no significant differences in LV function and morphology (all P > 0.05).

Similar results were obtained when analyzing the NTs in the EC of Cohort II; the co-localization between p-tau217/p-tau231 and p-tau231/p-tau205 was significantly lower, and p-tau217/p-tau205 showed a trend to lower co-localization in AD high compared to PART ( p = 0.02, p = 0.04, and p = 0.06, respectively).

21 , 40 participants) showed a trend of risperidone being associated with less weight gain than haloperidol (1.74 kg [−0.62; 4.10], test for subgroup differences: Chi2 = 5.07, d f = 1, p = 0.02).

During RTS, nocturnal RMSSD of SRC athletes (Mdn = 77.74 ms) showed a trend compared to controls (Mdn = 95.68 ms, p = 0.021, r = −0.382, p adjusted using false discovery rate = 0.126) and positively correlated to “drowsiness” (r = 0.523, p = 0.023, p adjusted = 0.046).

The total number of balloons popped also remained significantly associated with apathy, r(63) = 0.454, p < 0.001, and showed a trend towards a significant correlation with disinhibition, r(64) = 0.307, p = 0.021, after controlling for overall cognitive impairment (Supplementary Table 1 ).

In addition, the levels of cell-bound IFN-γ showed a trend to be increased with the combination of sertraline and RT, which was inversely associated with tumor weight (R = −0.607 p = 0.021) (Fig. 7b ).

Parent-child interaction frequency showed a trend towards significance in univariate analysis ( p = 0.021) but did not reach significance in multivariate analysis ( p = 0.117), suggesting it may still play a role in mitigating developmental risks. 3.8 ROC curve analysis of parents' electronic ST habits, young children's screen exposure and parent-child interaction on language development delay in young children The ROC curve analysis indicated that father's and mother's daily ST, along with total entertainment time, showed moderate discriminatory ability for predicting language development delays in young children ( Table 7 ).

Bipolar disorder polygenic risk score, childhood adversity and symptom dimensions BD-PRS showed a trend-level association with the positive dimension (β = −0.49, 95% CI = [−0.875, −0.102], p = 0.021) but no association with the negative (β = 0.09, 95% CI = [−0.288, 0.474], p = 0.654), manic (β = −0.19, 95% CI = [−0.582, 0.208], p = 0.387) or depressive dimensions (β = −0.20, 95% CI = [−0.585, 0.178], p = 0.330).

Complications (yes vs no) also showed a trend towards significance (OR: 3.20, 95% CI: 1.20–8.53, P = 0.021).